Current Landscape and Future Directions of Deprescribing and Polypharmacy Practices in Jordan

Overview

Journal Med Princ Pract

Publisher Karger

Specialties General Medicine
Medical Education

Date 2024 Aug 19

PMID 39159605

Authors

Muna Barakat

Razan Nassar

Lobna Gharaibeh

Samar Thiab

Abdulqadir J Nashwan

Affiliations

Soon will be listed here.

Abstract

This review explores the current landscape and future directions of deprescribing and polypharmacy practices in Jordan. The prevalence of polypharmacy, defined as the concurrent use of multiple medications by an individual, has been increasing in recent years due to various factors, such as population aging and the greater availability of medications. However, polypharmacy can lead to adverse drug events, suboptimal medication adherence, increased healthcare costs, and reduced quality of life. Deprescribing, on the other hand, involves the discontinuation or reduction of unnecessary or potentially harmful medications to improve patient outcomes. The findings presented in this review highlight the current state of deprescribing and polypharmacy practices in Jordan, including factors influencing their prevalence. Additionally, it discusses the challenges healthcare professionals face in implementing deprescribing strategies and identifies potential solutions for enhancing these practices in Jordanian healthcare settings. Moreover, this paper provides insights into future directions for deprescribing and polypharmacy practices in Jordan. Overall, this review offers valuable insights into the current landscape of deprescribing and polypharmacy practices in Jordan while also providing recommendations for future directions to optimize medication management strategies that can ultimately benefit patient outcomes within a sound healthcare system framework.

References

Reeve E, Wiese M, Hendrix I, Roberts M, Shakib S . People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to Deprescribe. J Am Geriatr Soc. 2013; 61(9):1508-14. DOI: 10.1111/jgs.12418. View

Ng B, Duong M, Lo S, Le Couteur D, Hilmer S . Deprescribing perceptions and practice reported by multidisciplinary hospital clinicians after, and by medical students before and after, viewing an e-learning module. Res Social Adm Pharm. 2021; 17(11):1997-2005. DOI: 10.1016/j.sapharm.2021.03.002. View

Maher R, Hanlon J, Hajjar E . Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2013; 13(1):57-65. PMC: 3864987. DOI: 10.1517/14740338.2013.827660. View

Moriarty F, Pottie K, Dolovich L, McCarthy L, Rojas-Fernandez C, Farrell B . Deprescribing recommendations: An essential consideration for clinical guideline developers. Res Social Adm Pharm. 2018; 15(6):806-810. DOI: 10.1016/j.sapharm.2018.08.014. View

Galazzi A, Lusignani M, Chiarelli M, Mannucci P, Franchi C, Tettamanti M . Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy. Int J Clin Pharm. 2016; 38(2):454-61. DOI: 10.1007/s11096-016-0279-4. View

Farrell B, Grad R, Howell P, Quast T, Reeve E . Deprescribing Guidelines: Value of an Interactive Mobile Application. PRiMER. 2020; 4:26. PMC: 7581200. DOI: 10.22454/PRiMER.2020.349237. View

Khezrian M, McNeil C, Murray A, Myint P . An overview of prevalence, determinants and health outcomes of polypharmacy. Ther Adv Drug Saf. 2020; 11:2042098620933741. PMC: 7294476. DOI: 10.1177/2042098620933741. View

Tjia J, Kutner J, Ritchie C, Blatchford P, Bennett Kendrick R, Prince-Paul M . Perceptions of Statin Discontinuation among Patients with Life-Limiting Illness. J Palliat Med. 2017; 20(10):1098-1103. PMC: 5647503. DOI: 10.1089/jpm.2016.0489. View

Gillespie R, Mullan J, Harrison L . Attitudes towards deprescribing and the influence of health literacy among older Australians. Prim Health Care Res Dev. 2020; 20:e78. PMC: 8060829. DOI: 10.1017/S1463423618000919. View

10.

Zimmerman K, Bell C, Donohoe K, Salgado T . Medicine, pharmacy and nursing trainees' perceptions of curriculum preparation to deprescribe and interprofessional roles in the deprescribing process. Gerontol Geriatr Educ. 2019; 41(1):63-84. DOI: 10.1080/02701960.2019.1661840. View

11.

Newton P, Levinson W, Maslen D . The geriatric medication algorithm: a pilot study. J Gen Intern Med. 1994; 9(3):164-7. DOI: 10.1007/BF02600035. View

12.

Morgan T, Williamson M, Pirotta M, Stewart K, Myers S, Barnes J . A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust. 2012; 196(1):50-3. DOI: 10.5694/mja11.10698. View

13.

Schackmann L, van Dijk L, Brabers A, Zwier S, Koster E, Vervloet M . Comprehensibility of a personalized medication overview compared to usual-care prescription drug labels. Front Pharmacol. 2022; 13:1004830. PMC: 9650257. DOI: 10.3389/fphar.2022.1004830. View

14.

Bilek A, Levy Y, Kab H, Andreev P, Garfinkel D . Teaching physicians the GPGP method promotes deprescribing in both inpatient and outpatient settings. Ther Adv Drug Saf. 2020; 10:2042098619895914. PMC: 6935879. DOI: 10.1177/2042098619895914. View

15.

Scott I, Le Couteur D . Physicians need to take the lead in deprescribing. Intern Med J. 2015; 45(3):352-6. DOI: 10.1111/imj.12693. View

16.

Linsky A, Gellad W, Linder J, Friedberg M . Advancing the Science of Deprescribing: A Novel Comprehensive Conceptual Framework. J Am Geriatr Soc. 2019; 67(10):2018-2022. PMC: 6800794. DOI: 10.1111/jgs.16136. View

17.

Reeve E, Wolff J, Skehan M, Bayliss E, Hilmer S, Boyd C . Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States. JAMA Intern Med. 2018; 178(12):1673-1680. PMC: 6583614. DOI: 10.1001/jamainternmed.2018.4720. View

18.

Thompson W, Reeve E, Moriarty F, MacLure M, Turner J, Steinman M . Deprescribing: Future directions for research. Res Social Adm Pharm. 2018; 15(6):801-805. PMC: 6422759. DOI: 10.1016/j.sapharm.2018.08.013. View

19.

McKean M, Pillans P, Scott I . A medication review and deprescribing method for hospitalised older patients receiving multiple medications. Intern Med J. 2015; 46(1):35-42. DOI: 10.1111/imj.12906. View

20.

Grischott T, Rachamin Y, Senn O, Hug P, Rosemann T, Neuner-Jehle S . Medication Review and Enhanced Information Transfer at Discharge of Older Patients with Polypharmacy: a Cluster-Randomized Controlled Trial in Swiss Hospitals. J Gen Intern Med. 2022; 38(3):610-618. PMC: 9432794. DOI: 10.1007/s11606-022-07728-6. View